key: cord-0729695-84n84qe4 authors: Soto, Dayana; Orozco, Jahir title: Peptide-based simple detection of SARS-CoV-2 with electrochemical readout date: 2022-03-21 journal: Anal Chim Acta DOI: 10.1016/j.aca.2022.339739 sha: 3f9f47e1b08bedf5eb36509f4445f39ea4d92373 doc_id: 729695 cord_uid: 84n84qe4 Coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is considered one of the worst pandemic outbreaks worldwide. This ongoing pandemic urgently requires rapid, accurate, and specific testing devices to detect the virus. We report a simple electrochemical biosensor based on a highly specific synthetic peptide to detect SARS-CoV-2 Spike protein. Unlike other reported electrochemical biosensors involving nanomaterials or complex approaches, our electrochemical platform uses screen-printed gold electrodes functionalized with the thiolated peptide, whose interaction with the Spike protein is directly followed by Electrochemical Impedance Spectroscopy. The electrochemical platform was Spike protein concentration-dependent, with high sensitivity and reproducibility and a limit of detection of 18.2 ng/mL when tested in Spike protein commercial solutions and 0.01 copies/mL in lysed SARS-CoV-2 particles. The label-free biosensor successfully detected the Spike protein in samples from infected patients straightforwardly in only 15 min. The simplicity of the proposed format combined with an on-demand designed peptide opens the path for detecting other pathogen-related antigens. The rapid expansion of the coronavirus 2019 (COVID- 19) , a disease caused by the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), was declared a pandemic in 2020 and continues today to threaten public health systems worldwide [1] [2] [3] [4] . The current diagnostic recommended by the World Health Organization (WHO) is based on the detection of the SARS-CoV-2 viral RNA by reverse transcriptase real-time polymerase chain reaction (RT-PCR) [5] . Although the RT-PCR is the gold standard method, it is time-consuming and requires specialized testing facilities with highly qualified personnel, which decreases the high number of daily samples essential to slow its spread. Besides, immunoassays based on the detection of viral structural proteins and serological methods that detect antibodies have some limitations related to low sensitivity, reduced efficiency and cross-reactivity. Therefore, developing accurate, specific and sensitive devices for the simple and rapid detection of the SARS-CoV-2 and early diagnosis of COVID 19 has a pivotal role in controlling the viral outbreak [5] [6] [7] Previous reports have found that Electrochemical Impedance Spectroscopy (EIS)-based biosensors rapidly detect bioreceptors associated with SARS-CoV-2 infection, with high sensitivity, specificity and reliability [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . In such biosensors, bioreceptors are anchored on the working electrode surface to directly bind to target molecules specifically, generating changes in the interfacial properties in a concentration-dependent manner [18] [19] [20] . The SARS-CoV-2 has also been detected electrochemically by immunosensors [14, [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] and genosensors [33] [34] [35] [36] . Furthermore, outstanding features of biosensors have been exploited in the detection of other viruses [37, 38] , pathogens [39] , other infections [18] , cancer biomarkers [40] [41] [42] and other diseases-related biomarkers [43] demonstrating to be promising analytical tools that can help to solve current diagnosis limitations [44] . Here, we report the first peptide-based biosensor for simple monitoring free Spike protein and SARS-CoV-2 viral particles in COVID-19 positive patients by EIS. Peptides are specific sequences of amino acids with similar selectivity, specificity and chemical nature as proteins but smaller sizes, higher stability against denaturation, cost-effectiveness, accessibility, easiness of modification, and more extensive chemical versatility [45, 46] . Therefore, peptides are ideal candidates to substitute proteins as bioreceptor in (bio)recognition and J o u r n a l P r e -p r o o f biosensing events. The biosensor uses a synthetic thiolated peptide bioreceptor chemisorbed at the working electrode of a screen-printed gold electrode (SPAuE) that directly interacted with the Spike protein and whose interaction was detected and quantified by EIS. The resultant device showed high sensitivity and reproducibility, low limit of detection (LOD) and a linear dynamic range of clinical relevance. Besides, the peptide-based biosensor was highly specific for SARS-CoV-2 and detected the Spike protein from COVID-19 positive patients in clinical samples. This is the first time the peptide has been incorporated in a transducer platform for SARS-CoV-2 sensing purposes of remarkable analytical performance. Performance, simplicity, and low cost not only underline the great potential of our biosensor for detecting the virus at the clinical level but for the on-demand design of peptide-based sensing platforms for detecting other viruses, pathogens, and disease biomarkers. interaction with a lysed sample and readout (right). The electrochemical performance of the as-functionalized platform was evaluated by CV The selectivity of the biosensor was assessed by comparing the response against We selected a thiolated synthetic peptide as a biomarker to develop the biosensor reported herein, inspired by the high interaction between the RBD region of the SARS-CoV-2 and the angiotensin-converting enzyme (ACE)-2 host receptor protein [48, 49] . Recent crystallographic studies revealed that the amino acid residues, mainly through polar residues present in the α1 helix of the peptidase domain of the ACE-2 protein, are the key to the interfacial interaction with the RBD protein of SARS-CoV-2 [4, 50] . It has been reported that depends on a pre-exponential factor (P) and an exponent (n) [55] [56] [57] [58] , as summarized in Table 1 . [51] . P values in Table 1 showed a decrease in the capacitive behavior of the system, and in the meantime, the n values for modified electrodes were less than one, consistent with a double layer pseudo-interfacial capacitance at the electrode/electrolyte interface [59] . Although the use of the theoretical model of the Randles Circuit for the adjustment of experimental data is widely extended; it is crucial to recognize that this model does not consider various factors involved in the biosensing process of the Spike protein, such as binding affinity, leaching, denaturation, transport phenomena, surface defects, among others; that may affect the results. Nevertheless, the very small values of Chi-squared function (χ2) for the best-fitted equivalent circuit, lower than 1.6 x 10 −3 , demonstrated that the curve showed herein and the experimental data from the mathematical fitting agreed (See S.I Fig. S1 A-C). Table 1 summarizes all the fitted electrochemical parameters. These results suggest that the anchorage of peptide and the interaction with the Spike protein decreased the capacitive current on modified-electrodes and decreased the charge transfer resistance, which indicates that the peptide-Spike protein recognition event was successful. J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f Once the functionality of the biosensor platform was established, the peptide concentration was optimized as a function of the increase in the difference of the charge transfer resistance (ΔRct) (Fig. 2) . The behavior of the functionalized electrode was evaluated with different concentrations of the peptide after blocking with MCH and incubation with 1.0 µg/mL of a Spike protein solution. The ΔRct for 0.25 and 0.7 mM concentrations were lower ( Fig. 2A -C) than for 0.50 mM of peptide solution (Fig. 2B) . These differences may be associated with the organization degree of the peptide at the modified-electrode surface. Accordingly, low concentrations of peptides seem to generate poor self-assembly of the monolayers, thus affecting the Spike protein recognition event. In contrast, a high concentration of peptide molecules could generate overlapping of peptide multilayers that limit the interaction of the specific segment of the peptide and the Spike protein. Fig. 2D shows At lower temperatures, the RBD protein has a closed conformation that disables binding to the peptide due to its burying receptor-binding residues [59] . and a LOD of 18.2 ng/mL, which results are higher than 1 fg/mL [60] and 2.9 ng/mL and 14.6 µA.mL/ng [61] , but comparable with 66 pg/mL and 14.9 %/nM [62] . Remarkably, the signal of our peptide-based biosensor was Spike protein concentration-dependent after only 15 min sample incubation. In an attempt to approach a real scenario, we construct a calibration curve estimating the ΔRct for viral particles of SARS-CoV-2 inactivated by UV-light ( Fig. 3C-D) . The data showed a linear correlation between 10 2 to 10 3 copies/mL with LOD of 0.01 copies/mL described by the equation ΔRct = 15308.5 log C -27759.1 and a correlation coefficient R 2 = 0.9801 (Inset Fig. 3D ). Considering the Spike protein levels [63, 64] and viral particles on human samples [14] ; our results indicate that the peptide-based biosensor can detect Spike protein in solution and viral particles at clinically relevant concentrations will be shown below. The specificity of the peptide-based biosensor is essential to reduce or avoid a false positive assignment. We considered herein 0.1 µg/mL of solutions that contain the Spike protein and compared it with those with RBD or β-1,4-GALT-5 glycosylated protein (Fig. 4A ). The Spike protein is a transmembrane protein containing two subunits, S1 and S2. S1 mainly contains an RBD responsible for recognizing the ACE-2 host cell surface receptor, and the S2 region contains essential elements needed for membrane fusion once in the host cell [65] . The platform's resultant ΔRct against the Spike protein and RBD, measured by EIS, exhibited a similar response with no statistically significant differences (p values are greater than 0.01). It means the RBD-peptide interaction of free RBD and RBD in the S1 region of the Spike protein are comparable. In contrast, the response was differential concerning β-1,4-GALT-5 and negative control with a very low β-1,4-GALT-5-peptide interaction, which could be explained by the presence of sialic acid in the β-1,4-GALT-5 [66] known as a receptor that binds to the S1 region of the Spike protein [65] . Subsequently, we estimated the Long-term stability is also a significant feature in developing biosensors, especially when thinking about a translational approach. Next, the stability of the resulting peptide-based biosensor was analyzed; the modified-electrodes were stored at 4 °C in a humid chamber and eventually tested their response with 0.1 µg/mL Spike protein solutions for 30 days based on the 3σ criteria (See Fig. S3A in SI). The stability was estimated by potting a control chart considering the first day of the study as the initial value. The upper and lower control limits were set at three times this value's standard deviation (3σ). The finding confirms that the J o u r n a l P r e -p r o o f response of the peptide-based biosensors was in between the control limits and retained 73.6 % of its initial response when tested up to 20 days of storage, which reveals the relative longterm stability of the biosensors related to the mixed self-assembled monolayer at the modified-electrodes surface. Finally, we checked the reproducibility and repeatability of the developed biosensor by interrogating a 0.1 µg/mL Spike solution. Five peptide-based biosensors were prepared independently and their impedimetric responses were measured, three times each, under identical experimental conditions (See Fig. S3B in SI). The intra-and inter-electrode relative standard deviation (RSD) was estimated to be 4.1 (n = 5) and 2.2% (n = 3), which indicates the high repeatability and reproducibility of the biosensors developed, respectively. The biosensor was challenged with nasopharyngeal swab samples from nine COVID-19 positive patient samples and three negative samples. The clinical diagnostic feasibility of the peptide-based biosensor was evaluated by analyzing the lysed diluted samples with different CT (cycle threshold) values, tested by RT-PCR, as reported in Table 2 , SI. It is important to remark that RT-PCR is the gold standard technique for diagnosing COVID-19 based on detecting viral RNA from SARS-CoV-2 and used herein to estimate the samples' viral loading, i.e., lower the CT higher the viral loading. Rather than RNA detection, our peptidebased device was designed to detect the Spike protein from viral swab particles ( Table 2 in SI) . Therefore, although results from RT-PCR can't be directly compared with ours, they are clear evidence of a positive or negative sample. Fig. 5 shows that the biosensor can differentiate between positive and negative nasopharyngeal swab samples concerning the controls and differentiate the viral loading, i.e., high, middle, or low. It was evident that the biosensor is responding to the presence of Spike protein in COVID-19 positive samples with statistically significant differences (p<0.01) concerning the negative samples and the negative control and no statistically significant differences between the negative samples and the negative control (p>0.01). These results agree with those from RT-PCR, thus demonstrating the biosensor's great potential for detecting the Spike protein from SARS-CoV-2 and its correlation with a rapid diagnosis of COVID-19. J o u r n a l P r e -p r o o f We developed the first peptide-based impedimetric biosensor that detected and quantified Rapid and efficient detection of the SARS-CoV-2 Spike protein using an electrochemical aptamer-based sensor Paperbased electrochemical biosensor for diagnosing COVID-19: Detection of SARS-CoV-2 antibodies and antigen Detection of SARS-CoV-2 Viral Particles Using Direct, Reagent-Free Electrochemical Sensing The first-in-class peptide binder to the SARS-CoV-2 Spike protein Ultrasensitive detection of SARS-CoV-2 spike protein in untreated saliva using SERS-J o u r n a l P r e -p r o o f based biosensor Rapid SARS-CoV-2 detection using electrochemical immunosensor Detection of SARS-CoV-2 Viral Particles Using Direct, Reagent-Free Electrochemical Sensing New impedimetric sandwich immunosensor for ultrasensitive and highly specific detection of spike receptor binding domain protein of SARS-CoV-2 Boron doped diamond thin films for the electrochemical detection of SARS-CoV-2 S1 protein Aptamer-based electrochemical biosensor for rapid detection of SARS-CoV-2: Nanoscale electrodeaptamer-SARS-CoV-2 imaging by photo-induced force microscopy High affinity dimeric aptamers enable rapid electrochemical detection of Wild-Type and B.1.1.7 SARS-CoV-2 in unprocessed saliva Enhancing the performance of paper-based electrochemical impedance spectroscopy nanobiosensors: An experimental approach Rapid detection of SARS-CoV-2 antibodies using electrochemical impedance-based detector A novel Method for the detection of SARS-CoV-2 based on graphene-impedimetric immunosensor Nanostructured sensor platform based on organic polymer conjugated to metallic nanoparticle for the impedimetric detection of SARS-CoV-2 at various stages of viral infection Sensing of COVID-19 antibodies in seconds via aerosol Jet nanoprinted reduced-graphene-oxidecoated 3D electrodes Phosphoglycan-sensitized platform for specific detection of anti-glycan IgG and IgM antibodies in serum Development of flexible electrochemical impedance spectroscopy-based biosensing platform for rapid screening of SARS-CoV-2 inhibitors Low-cost biosensor for rapid detection of SARS-CoV-2 at the point of care Screen-printed Rapid and efficient detection of the SARS-CoV-2 Spike protein using an electrochemical aptamer-based sensor 3D-Printed COVID-19 immunosensors with electronic readout Rapid detection of COVID-19 causative virus (SARS-CoV-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor Colorimetric and electrochemical detection of SARS-CoV-2 spike antigen with a gold nanoparticle-based biosensor Electrochemical immunosensor with Cu2O nanocube coating for detection of SARS-CoV-2 spike protein Magnetic beads combined with carbon black-based screen-printed electrodes for COVID-19: A reliable and miniaturized electrochemical immunosensor for SARS-CoV-2 detection in saliva Detection of SARS-CoV-2 viral particles using direct, reagent-free electrochemical sensing Rapid detection of SARS-CoV-2 antigens using high-purity semiconducting single-walled carbon nanotube-based field-effect transistors Hitting the diagnostic sweet spot: Point-of-care SARS-CoV-2 salivary antigen testing with an off-the-shelf glucometer An electrochemical SARS-CoV-2 biosensor inspired by glucose test strip manufacturing processes Functionalized TiO2 nanotubebased electrochemical biosensor for rapid detection of SARS-CoV-2 Ultrasensitive supersandwich-type electrochemical sensor for SARS-CoV-2 from the infected COVID-19 patients using a smartphone A nanoscale genosensor for early detection of COVID-19 by voltammetric determination of RNA-dependent RNA polymerase (RdRP) sequence of SARS-CoV-2 virus Rapid, ultrasensitive, and quantitative detection of SARS-CoV-2 using antisense oligonucleotides directed electrochemical biosensor chip An electrochemical biosensor for sensitive analysis of the SARS-CoV-2 RNA Gold nanoparticle/DNA-based nanobioconjugate for electrochemical detection of Zika virus Genosensors for differential detection of Zika virus Electrochemical performance of a DNA-based sensor device for detecting toxic algae Antiviral nanostructured surfaces reduce the viability of SARS-CoV Recent achievements and challenges on nanomaterial based electrochemical biosensors for the detection of colon and Lung cancer biomarkers Electrochemical immnosensing of ST2: A checkpoint target in Cancer diseases Biosensors and nanobiosensors for rapid detection of autoimmune diseases: a review Emerging Trends in Nanobiosensor Peptide-based biosensors Peptide based biosensors Gold nanoparticle-modified ultramicroelectrode arrays for biosensing: A comparative assessment Human-IgG-neutralizing monoclonal antibodies block the SARS-CoV-2 infection Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 The first-in-class peptide binder to the SARS-CoV-2 Spike protein Aptasensor based on screenprinted electrode for breast cancer detection in undiluted human serum Nanomaterials based electrochemical nucleic acid biosensors for environmental monitoring: A review Design of electrochemical biosensors with peptide probes as the receptors of targets and the inducers of gold nanoparticles assembly on electrode surface The accurate use of impedance analysis for the study of microbial electrochemical systems Label-free electrochemical detection of malaria-infected red blood cells Electroactive graphene-multi-walled carbon nanotube hybrid supported impedimetric immunosensor for the detection of human cardiac troponin-I Electroanalysis of an Iron@Graphene-Carbon Nanotube Hybrid Material Investigation of the effect of temperature on the structure of SARS-CoV-2 Spike protein by molecular dynamics simulations Development of a Portable, Ultra-Rapid and Ultra-Sensitive Cell-Based Biosensor for the Direct Detection of the SARS-CoV-2 S1 Spike Protein Antigen Diagnosis with a Gold-Nanoarchitecture-Assisted Laser-Scribed Graphene Biosensor Aptamer-based electrochemical biosensor for rapid detection of SARS-CoV-2: Nanoscale electrodeaptamer-SARS-CoV-2 imaging by photo-induced force microscopy Crossreactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients Expression, Glycosylation, and Modification of the Spike (S) Glycoprotein of SARS CoV Molecular frameworks of polymerized 3-aminobenzoic acid for chemical modification and electrochemical recognition Peptide-based simple detection of SARS-CoV-2 with electrochemical readout The authors whose names are listed immediately below certify that Since 2017, she has been part of the electrochemical biosensing research line from the Max Planck Tandem Group in Nanobioengineering at the UdeA. Her areas of interest include nano(bio)sensors, electrochemistry, nanomaterials, enzymatic catalysis, surface chemistry, characterization techniques and development of analytical detection tools of biomedical interest He completed three postdoctoral stays for seven years at the Banyuls sur Mer Oceanological Observatory (France), the Department of Nanoengineering at UCSD (USA) and the Catalan Institute for Nanoscience and Nanotechnology (Spain). He is currently the group leader of the Max Planck Tandem Group in Nanobioengineering (UdeA) Supplementary data associated with this article can be found, in the online version, at XXXXXX.